129 related articles for article (PubMed ID: 16516972)
1. 5-ht5A receptors as a therapeutic target.
Thomas DR
Pharmacol Ther; 2006 Sep; 111(3):707-14. PubMed ID: 16516972
[TBL] [Abstract][Full Text] [Related]
2. SB-699551-A (3-cyclopentyl-N-[2-(dimethylamino)ethyl]-N-[(4'-{[(2-phenylethyl)amino]methyl}-4-biphenylyl)methyl]propanamide dihydrochloride), a novel 5-ht5A receptor-selective antagonist, enhances 5-HT neuronal function: Evidence for an autoreceptor role for the 5-ht5A receptor in guinea pig brain.
Thomas DR; Soffin EM; Roberts C; Kew JN; de la Flor RM; Dawson LA; Fry VA; Coggon SA; Faedo S; Hayes PD; Corbett DF; Davies CH; Hagan JJ
Neuropharmacology; 2006 Sep; 51(3):566-77. PubMed ID: 16846620
[TBL] [Abstract][Full Text] [Related]
3. Novel 5-HT5A receptor antagonists ameliorate scopolamine-induced working memory deficit in mice and reference memory impairment in aged rats.
Yamazaki M; Okabe M; Yamamoto N; Yarimizu J; Harada K
J Pharmacol Sci; 2015 Mar; 127(3):362-9. PubMed ID: 25837935
[TBL] [Abstract][Full Text] [Related]
4. Spinal 5-HT₅A receptors mediate 5-HT-induced antinociception in several pain models in rats.
Muñoz-Islas E; Vidal-Cantú GC; Bravo-Hernández M; Cervantes-Durán C; Quiñonez-Bastidas GN; Pineda-Farias JB; Barragán-Iglesias P; Granados-Soto V
Pharmacol Biochem Behav; 2014 May; 120():25-32. PubMed ID: 24517902
[TBL] [Abstract][Full Text] [Related]
5. Cognitive dysfunction in neuropsychiatric disorders: selected serotonin receptor subtypes as therapeutic targets.
Terry AV; Buccafusco JJ; Wilson C
Behav Brain Res; 2008 Dec; 195(1):30-8. PubMed ID: 18241938
[TBL] [Abstract][Full Text] [Related]
6. The effects of a 5-HT5A receptor antagonist in a ketamine-based rat model of cognitive dysfunction and the negative symptoms of schizophrenia.
Nikiforuk A; Hołuj M; Kos T; Popik P
Neuropharmacology; 2016 Jun; 105():351-360. PubMed ID: 26826431
[TBL] [Abstract][Full Text] [Related]
7. 5-HT7 receptors.
Thomas DR; Hagan JJ
Curr Drug Targets CNS Neurol Disord; 2004 Feb; 3(1):81-90. PubMed ID: 14965246
[TBL] [Abstract][Full Text] [Related]
8. A review of central 5-HT receptors and their function.
Barnes NM; Sharp T
Neuropharmacology; 1999 Aug; 38(8):1083-152. PubMed ID: 10462127
[TBL] [Abstract][Full Text] [Related]
9. 5-HT2A antagonists in psychiatric disorders.
de Angelis L
Curr Opin Investig Drugs; 2002 Jan; 3(1):106-12. PubMed ID: 12054060
[TBL] [Abstract][Full Text] [Related]
10. Serotonin 5-HT2A and 5-HT5A receptors are expressed by different motoneuron populations in rat Onuf's nucleus.
Xu C; Giuliano F; Sun XQ; Brisorgueil MJ; Leclerc P; Vergé D; Conrath M
J Comp Neurol; 2007 Jun; 502(4):620-34. PubMed ID: 17394137
[TBL] [Abstract][Full Text] [Related]
11. Distribution of the 5-HT5A serotonin receptor mRNA in the human brain.
Pasqualetti M; Ori M; Nardi I; Castagna M; Cassano GB; Marazziti D
Brain Res Mol Brain Res; 1998 May; 56(1-2):1-8. PubMed ID: 9602024
[TBL] [Abstract][Full Text] [Related]
12. Medicinal chemistry strategies to 5-HT(6) receptor ligands as potential cognitive enhancers and antiobesity agents.
Holenz J; Pauwels PJ; Díaz JL; Mercè R; Codony X; Buschmann H
Drug Discov Today; 2006 Apr; 11(7-8):283-99. PubMed ID: 16580970
[TBL] [Abstract][Full Text] [Related]
13. Serotonin1A receptors in the pathophysiology of schizophrenia: development of novel cognition-enhancing therapeutics.
Sumiyoshi T; Bubenikova-Valesova V; Horacek J; Bert B
Adv Ther; 2008 Oct; 25(10):1037-56. PubMed ID: 18839076
[TBL] [Abstract][Full Text] [Related]
14. Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents.
Bonaventure P; Kelly L; Aluisio L; Shelton J; Lord B; Galici R; Miller K; Atack J; Lovenberg TW; Dugovic C
J Pharmacol Exp Ther; 2007 May; 321(2):690-8. PubMed ID: 17314195
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of 5-HT7 receptors in mood disorders.
Mnie-Filali O; Lambas-Señas L; Scarna H; Haddjeri N
Curr Drug Targets; 2009 Nov; 10(11):1109-17. PubMed ID: 19702552
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 5-HT4 and 5-HT7 receptor expression and function in the circular muscle of the human colon.
Irving HR; Tan YY; Tochon-Danguy N; Liu H; Chetty N; Desmond PV; Pouton CW; Coupar IM
Life Sci; 2007 Mar; 80(13):1198-205. PubMed ID: 17258778
[TBL] [Abstract][Full Text] [Related]
17. Cloning, genomic organization and functionality of 5-HT(7) receptor splice variants from mouse brain.
Gellynck E; Laenen K; Andressen KW; Lintermans B; De Martelaere K; Matthys A; Levy FO; Haegeman G; Vanhoenacker P; Van Craenenbroeck K
Gene; 2008 Dec; 426(1-2):23-31. PubMed ID: 18793707
[TBL] [Abstract][Full Text] [Related]
18. Studies on the neuroendocrine role of serotonin.
Jørgensen HS
Dan Med Bull; 2007 Nov; 54(4):266-88. PubMed ID: 18208678
[TBL] [Abstract][Full Text] [Related]
19. Memory time-course: mRNA 5-HT1A and 5-HT7 receptors.
Perez-Garcia G; Meneses A
Behav Brain Res; 2009 Aug; 202(1):102-13. PubMed ID: 19447286
[TBL] [Abstract][Full Text] [Related]
20. Medicinal chemistry of 5-HT5A receptor ligands: a receptor subtype with unique therapeutical potential.
Volk B; Nagy BJ; Vas S; Kostyalik D; Simig G; Bagdy G
Curr Top Med Chem; 2010; 10(5):554-78. PubMed ID: 20166946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
